Transcriptomic, Redox Status and Adipocytokine Profiles in Metabolic Dysfunction-Associated Steatotic Liver Disease: Impact of Coexisting Type 2 Diabetes
Medical Sciences · 2025
DOI: 10.3390/medsci13040326 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Sciences, 2025. Verfasst von Sanja Erceg und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Serbia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Adipokines, Fatty Liver, Transcriptome. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technological Development and Innovation, Republic of Serbia.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Metabolic dysfunction-associated steatotic liver disease (MASLD) commonly coexists with type 2 diabetes (T2D), but their independent contributions to redox imbalance, inflammation and immune signaling remain uncertain.
Objectives
This study aimed to evaluate whether the presence of MASLD alone, and the presence of T2D within MASLD, are independently associated with high-risk profiles of oxidative/antioxidant markers, peripheral blood mononuclear cell (PBMC) gene expression and adipocytokines.
Methods
A total of 190 participants were categorized via abdominal ultrasound as controls (n = 46), MASLD (n = 83) or MASLD with T2D (n = 61). Measurements included advanced oxidation protein products (AOPP) and paraoxonase-1 (PON1) activity in serum; messenger ribonucleic acids expression of cluster of differentiation 36 (CD36), Toll-like receptor 9 (TLR9), and glutathione peroxidase-1 in PBMC; and adiponectin, leptin, and resistin in plasma. Biomarker values were adjusted and statistical comparisons among groups were performed using the Quade test. Subsequently, biomarkers were stratified into tertiles to examine associations between high-risk biomarker levels and the presence of MASLD or T2D in patients with MASLD using multivariate binary logistic regression.
Results
Multivariate analysis showed that MASLD presence was independently associated with both increased AOPP and decreased resistin levels in the circulation. Furthermore, T2D presence in patients with MASLD was independently associated with increased CD36 and decreased TLR9 gene expression in PBMCs, as well as elevated circulating leptin levels.
Conclusions
Collectively, these findings underscore the complex interplay between oxidative stress, insulin resistance, inflammation, and immune signaling in the pathogenesis of MASLD, which are fundamental factors contributing to this condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Serbia.
- Department of Pharmacological and Biomolecular Sciences, University of Milan, 20133 Milan, Italy.
- Clinical Department for Gastroenterology and Hepatology, University Medical Center Zvezdara, 11120 Belgrade, Serbia.
- Department of Laboratory Diagnostics, Clinical Hospital Center Zemun, 11080 Belgrade, Serbia.
- Faculty of Medicine, University of Montenegro, 81000 Podgorica, Montenegro.
- Center for Laboratory Diagnostics, Primary Health Care Center, 81000 Podgorica, Montenegro.
ORCID-Profile: Sanja Erceg, Ana Ninić, Jelena Kotur-Stevuljević, Omar Ben Mariem, Miloš Mitrović, Jelena Munjas, Miron Sopić, Aleksandra Klisic
Förderung
- Ministry of Science, Technological Development and Innovation, Republic of Serbia
Zitieren
APA
Erceg, S., Ninić, A., Kotur-Stevuljević, J., Ben Mariem, O., Mitrović, M., Munjas, J., Sopić, M., Misita, B., Mamić, M., Klisic, A., & Tomašević, R. (2025). Transcriptomic, Redox Status and Adipocytokine Profiles in Metabolic Dysfunction-Associated Steatotic Liver Disease: Impact of Coexisting Type 2 Diabetes. Medical Sciences. https://doi.org/10.3390/medsci13040326
Vancouver
Erceg S, Ninić A, Kotur-Stevuljević J, Ben Mariem O, Mitrović M, Munjas J, et al. Transcriptomic, Redox Status and Adipocytokine Profiles in Metabolic Dysfunction-Associated Steatotic Liver Disease: Impact of Coexisting Type 2 Diabetes. Medical Sciences. 2025. doi:10.3390/medsci13040326
BibTeX
@article{Erceg2025,
author = {Erceg, Sanja and Ninić, Ana and Kotur-Stevuljević, Jelena and Ben Mariem, Omar and Mitrović, Miloš and Munjas, Jelena and Sopić, Miron and Misita, Boško and Mamić, Milica and Klisic, Aleksandra and Tomašević, Ratko},
title = {Transcriptomic, Redox Status and Adipocytokine Profiles in Metabolic Dysfunction-Associated Steatotic Liver Disease: Impact of Coexisting Type 2 Diabetes},
journal = {Medical Sciences},
year = {2025},
doi = {10.3390/medsci13040326}
}
EUVIMED